Delivery Order SPE2DB20D3101-SPE2DB25FRTN1
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine 18mg tablets (30-count units) under a firm fixed-price contract valued at $2,854.91, with completion targeted for August 26, 2025. This non-set-aside competitive award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a contract value of $1,935.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction with an ultimate completion date of August 25, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $1,453.90 for the supply of Atomoxetine HCL 10 mg capsules (30-count units). This award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, to be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,000.60 firm fixed-price contract is for the supply of 4,565,670,077 units of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of September 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger...
- The Defense Logistics Agency awarded a $77,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of 25mg Atomoxetine hydrochloride. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 3, 2023 in support of the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the context or purpose of the requested pharmaceutical products. The award was made using an unspecified...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atomoxetine HCl 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $2,969.40 and a period of performance through April 2025. This contract is not set-aside and was awarded as a firm-fixed price...
- The Defense Logistics Agency awarded a $197,160 delivery order to Amerisourcebergen Drug Corporation for atomoxetine hydrochloride 40mg capsules. Under this firm fixed price contract, Amerisourcebergen will deliver 30 boxes of the generic attention deficit hyperactivity disorder medication to a facility in Conshohocken, Pennsylvania by July 7, 2023 to support the Department of Defense's medical supply needs. As a top 100 contractor on the DLA's Pharmaceutical Prime Vendor program,...
- The Defense Logistics Agency awarded a $179,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg Atomoxetine HCl capsules. As the prime contractor, Amerisourcebergen will deliver 30 capsules to an address in Conshohocken, Pennsylvania, fulfilling the contract within a day of the start date on August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders under various...